Skip to main content

Table 1 Characteristics of HIV-infected patients. Baseline clinical and demographic characteristics of HIV-infected patients, who completed the study (n = 79)

From: Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses

Variables Vaccine 10 μg Vaccine 40 μg p
No. patients (%) 39 (49.3) 40 (50.7) -
Gender male – No. (%) 27 (69.2) 29 (72.5) 0.749
Mean age (years ± s.d.) 35.6 ± 8.12 34.1 ± 7.6 0.378
HIV exposure – No. (%)    
Heterosexual 18 (45%) 16 (41%) 0.721
Homo or bisexual 22 (55%) 23 (59%)  
Diagnosis of HIV (months ± s.d.) 40.6 ± 35.4 40.2 ± 32.65 0.960
Mean CD4 count (cel/mm3 ± s.d.) 245 ± 217.9 225.45 ± 189.7 0.671
CD4 cel/mm3 / No. (%)    
< 200 20 (51.3%) 21 (52.5%) 0.914
≥ 200 19 (48.8%) 19 (47.5%)  
Viral load (copies/mL) 75,187 ± 153,305 67,335 ± 112,742 0.811
Viral load (copies/mL) – No. (%)    
≤ 400 6 (20%) 9 (25%) 0.860
400 – ≤ 20,000 11 (36.6%) 11 (30.6%)  
≥ 20,000 13 (43.3%) 16 (44.4%)  
AIDS-defining illness – No. (%) 17 (43.6) 10 (25) 0.082
Treatment with HAART* – No. (%) 22 (56.4) 29 (72.5) 0.135
PI 20 (51.2) 23 (57.5)  
NNRTI 1 (2.6) 4 (10)  
PI + NNRTI or 3 NRTI 1 (2.6) 2 (5)  
  1. PI: Protease inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; NRTI: Nucleoside reverse transcriptase inhibitor.